Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.

Abstract

The cerebrospinal fluid is a valuable diagnostic fluid that is underutilized. A number of classical neurochemical tests and newer biomarkers of neuropathology may be performed on the cerebrospinal fluid from patients with clinical signs of progressive neurological disease to assist and complement diagnosis. Here, we discuss how they may be employed in the… (More)
DOI: 10.2217/bmm.12.47

Topics

Cite this paper

@article{Zetterberg2012ClinicalUO, title={Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.}, author={Henrik Zetterberg and Michael Pt Lunn and Sanna-Kaisa Herukka}, journal={Biomarkers in medicine}, year={2012}, volume={6 4}, pages={371-6} }